The Clinical Development & Regulatory Strategy (CDRS) sub-team of the Subcutaneous (SC) Drug Development and Delivery Consortium is excited to announce their upcoming virtual workshop ‘Roadmapping the Clinical and Regulatory Paths of SC Products and Technologies’, sponsored through AAPS (https://subcutaneousconsortium.org/cdrs-workshop-announcement/)
In this workshop, taking place February 23rd, we will bring industry professionals, academics, and regulatory experts together to share knowledge on two topics of significant interest:
- Technologies to facilitate high-dose SC administration
- Trial designs and regulatory considerations for different SC development paths.
We invite all professionals in the industry, academic, or government/regulatory sectors focused on SC development and the regulatory review process interested in participating in the workshop to learn more through visiting our workshop webpage: https://www.aaps.org/education-and-research/workshops/scproducts
English